← Today’s ReceiptsSource pending
Public-record receiptR-PASource pending
Daniel Meuser disclosed SELL $NVDA
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$250K – $500K
Filed
2025-08-20
Trade date
2025-02-11
Disclosure lag
190 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 190 days after the trade date, beyond the standard 45-day STOCK Act window.
3The disclosed range is $250K – $500K, which is the public reporting band rather than an exact profit or loss figure.
453 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Daniel Meuser, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 6 lobbying filings.
Source
source pending
Source: indexed congressional disclosure; official source link pending · filed 2025-08-20 · disclosed 190d after transaction
Market context
NVIDIA Corporation
Sector: Technology
Vs SPY: 29.6%
Factual flags
- Filed after the standard 45-day STOCK Act window.
- 6 lobbying filings linked to this ticker.
- 53 nearby same-ticker disclosures in the surrounding 30-day window.
- NVDA transaction date was 23d after a public lobbying filing by NVIDIA CORPORATION ($80,000); committee-sector context: Industrials; this is timing context, not a finding of intent.
- Filed 190 days after the reported transaction date (standard disclosure window: 45 days).
- Disclosed range upper bound: $500,000.
Member trail
Daniel Meuser
U.S. House · PA-9
House Committee on Financial ServicesHouse Committee on Small Business
Ticker trail
$NVDA
NVIDIA Corporation
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.